KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Aug 05, 2019 $9.09 $9.11 $8.81 $8.87 792 260
Aug 02, 2019 $9.74 $9.80 $9.25 $9.30 884 269
Aug 01, 2019 $10.11 $10.20 $9.75 $9.82 727 108
Jul 31, 2019 $10.40 $10.49 $10.09 $10.12 504 646
Jul 30, 2019 $10.22 $10.43 $10.18 $10.40 518 076
Jul 29, 2019 $10.44 $10.44 $10.08 $10.34 519 999
Jul 26, 2019 $10.35 $10.46 $10.22 $10.43 419 005
Jul 25, 2019 $10.56 $10.65 $10.17 $10.28 1 042 617
Jul 24, 2019 $10.35 $10.67 $10.16 $10.59 887 556
Jul 23, 2019 $10.35 $10.58 $10.27 $10.35 847 247
Jul 22, 2019 $9.83 $10.30 $9.69 $10.30 971 979
Jul 19, 2019 $10.13 $10.24 $9.78 $9.82 984 344
Jul 18, 2019 $10.37 $10.37 $9.75 $10.11 1 614 243
Jul 17, 2019 $10.46 $10.51 $10.12 $10.37 707 813
Jul 16, 2019 $11.35 $11.41 $10.44 $10.45 1 599 533
Jul 15, 2019 $11.46 $11.53 $11.33 $11.38 335 997
Jul 12, 2019 $11.52 $11.60 $11.21 $11.45 509 914
Jul 11, 2019 $11.55 $11.68 $11.35 $11.52 728 994
Jul 10, 2019 $11.40 $11.62 $11.22 $11.48 1 146 523
Jul 09, 2019 $11.27 $11.45 $11.17 $11.43 506 461
Jul 08, 2019 $11.42 $11.47 $11.06 $11.34 740 520
Jul 05, 2019 $11.58 $11.80 $11.35 $11.40 448 787
Jul 03, 2019 $11.53 $11.74 $11.33 $11.71 286 108
Jul 02, 2019 $11.79 $11.88 $11.26 $11.44 1 134 168
Jul 01, 2019 $11.98 $12.24 $11.66 $11.83 1 032 885
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT